Welcome
Support Centre
09 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A spectral analysis of human brain tissue
ISRCTN ISRCTN37780318
ClinicalTrials.gov identifier
Public title A spectral analysis of human brain tissue
Scientific title A spectral analysis of human brain tissue: A single centre non-randomised intra-operative imaging trial
Acronym N/A
Serial number at source 7568
Study hypothesis When performing surgery it is essential to identify normal and abnormal brain to guide where surgery should be performed. Computed tomography (CT) and magnetic resonance imaging (MRI) guided surgery is expensive and can have its limitations. It has been hypothesised however that the light reflected from the human brain is subtly different between normal and abnormal tissue. This is so subtle that as to not be apparent to the naked eye but may be detectable if the light is split into its individual wavelengths' and analysed by a very sensitive camera. If these differences are detectable then this could form the basis of new ways of making surgery safer.
Ethics approval Southampton and Southwest Hampshire Research Ethics Committee approved on the 22nd February 2007 (ref: 06/Q1704/139)
Study design Single centre non-randomised interventional diagnosis and screening trial
Countries of recruitment United Kingdom
Disease/condition/study domain Topic: Neurological; Subtopic: Neurological (all Subtopics); Disease: Nervous system disorders
Participants - inclusion criteria Any patient (over 16 years) undergoing craniotomy in Wessex Neurological Centre
Participants - exclusion criteria 1. Aged less than 16 years
2. Pregnancy
3. Prisoners
4. Patients incapable of consent
Anticipated start date 01/06/2007
Anticipated end date 01/06/2012
Status of trial Ongoing
Patient information material Not available in web format, please use contact details below to request a patient information sheet
Target number of participants Planned sample size: 200
Interventions Any patient undergoing craniotomy in the Wessex Neurological Centre will be considered. Appropriate consent will be obtained from the patient. At surgery up to five image acquisitions will be made. Each image acquisition will last up to 2 minutes and will consist of the full spectral analysis at fixed points followed by field images of fixed wavelengths. A photographic image and copy of the MRI scan will also be take to correlate spectral traces with conventional means of identifying normal and abnormal tissue. These images will then be analysed post-operatively and not be used to guide surgery or influence patient management.

The main arm of the trial will attempt to differentiate normal and abnormal brain. This will be done in patients under general anaesthetic as described above. The second arm will try to assess if the reflectance of the brain changes with function. This will be a smaller cohort of patients, as they will be undergoing awake craniotomy. During surgery images will be obtained before and during basic tasks performed for standard cortical mapping such as speech and hand squeezing to assess for any changes.

Data will be collected on a laptop computer before applying noise reduction and normalising data. Graphical representations of spectroscopic traces will be assessed for unusual signatures and differences between pathological and non-pathological tissue and between functioning and non-functioning cortex assess using a student’s t-test. Data will be stored anonymously on a networked university computer for up to ten years.

The duration on the intervention is 10 minutes added to the usual surgery time. This group of patients are not followed up for trial purposes. There are no treatment arms here: images are acquired for research purposes without any management implications for the individual patients.
Primary outcome measure(s) Difference in reflection between normal brain tissue and abnormal brain tissue, acquired at the time of image acquisition
Secondary outcome measure(s) No secondary outcome measures
Sources of funding National Institute for Health Research (NIHR) (UK) - Central Commissioning Facility (CCF): New and Emerging Applications of Technology (NEAT) Programme
Trial website
Publications
Contact name Prof  William  Gray
  Address Division of Clinical Neurosciences
Tremona Road
  City/town Southampton
  Zip/Postcode SO16 6YD
  Country United Kingdom
  Email cnsadmin@soton.ac.uk
Sponsor University of Southampton (UK)
  Address Aldermoor Close
  City/town Southampton
  Zip/Postcode SO16 5ST
  Country United Kingdom
  Sponsor website: http://www.soton.ac.uk/
Date applied 30/06/2010
Last edited 18/08/2010
Date ISRCTN assigned 30/06/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central